Alber, G., K. M. Kim, P. Weiser, C. Riesterer, R. Carsetti, and M. Reth. 1993. Molecular mimicry of the antigen receptor signalling motif by transmembrane proteins of the Epstein-Barr virus and the bovine leukemia virus. Curr. Biol. 3:333-339.
Alexandersen, S., S. Carpenter, J. Christensen, T. Stordgaard, B. Viuff, Y. Wannemuehler, J. Belousov, and J. Roth. 1993. Identification of alternatively spliced mRNAs encoding potential new regulatory proteins in cattle infected with bovine leukemia virus. J. Virol. 67:39-52.
Beaufils, P., D. Choquet, R. Mamoun, and B. Malissen. 1993. The (YXXL/ I)2 motif found in the cytoplasmic segments of the bovine leukemia virus envelope protein and Epstein-Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events. EMBO J. 12:5105-5112.
Derse, D., J. Mikovits, M. Polianova, B. Felber, and F. Ruscetti. 1995. Virions released from cells transfected with a molecular clone of human T-cell leukemia virus type I give rise to primary and secondary infections in T cells. J. Virol. 69:1907-1912.
Harrel, R., G. Ciancíolo, T. Copeland, S. Oroszlan, and R. Snyderman. 1986. Suppression of the respiratory burst of human monocytes by synthetic peptide homologous to envelope proteins of human and animal retroviruses. J. Immunol. 136:3517-3520.
Harris, D., G. Cianciolo, R. Snyderman, S. Argov, and H. Korea. 1987. Inhibition of human natural killer cell activity by a synthetic peptide homologous to a conserved region in the retroviral protein p15E. J. Immunol. 138:889-894.
Kettmann, R., A. Burny, I. Callebaut, L. Droogmans, M. Mammerickx, L. Willems, and D. Portetelle. 1994. Bovine leukemia virus, p. 39-81. In J. Levy (ed.), The Retroviridae, vol. 3. Plenum Press, New York.
Kimata, J., F. Wong, J. Wang, and J. Ratner. 1994. Construction and characterization of infectious human T-cell leukemia virus type I molecular clones. Virology 204:656-664.
Kleinennan, E., L. Lachman, R. Knowles, R. Snyderman, and G. Cianciolo. 1987. A synthetic peptide homologous to the envelope proteins of retroviruses inhibits monocyte-mediated killing by inactivating interleukin 1. J. Immunol. 139:2329-2337.
Kushida, S., H. Mizusawa, M. Matsumura, H. Tanaka, Y. Ami, M. Hori, K.-I. Yagami, T. Kameyama, Y. Tanaka, A. Yoshida, H. Nyunoya, K. Shimotohno, Y. Iwasaki, K. Uchida, and M. Miwa. 1994. High incidence of HAM/TSP-like symptoms in WKA rats after administration of human T-cell leukemia virus type 1-producing cells. J. Virol. 68:7221-7226.
Ogasawara, M., G. Cianciolo, R. Snyderman, M. Mitani, R. Good, and N. Day. 1988. Human IFN-γ production is inhibited by a synthetic peptide homologous to retroviral envelope protein. J. Immunol. 141:614-619.
Portetelle, D., K. Umbach, A. Burny, M. Mammerickx, P. Desmettre, M. Riviere, J. Zavada, and E. Paoletti. 1991. Recombinant vaccinia virus expression of the bovine leukemia virus envelope gene and protection of immunized sheep against infection. Vaccine 9:194-200.
Portetelle, D., M. Mammerickx, and A. Burny. 1989. Use of two monoclonal antibodies in an ELISA test for the detection of antibodies to bovine leukemia virus envelope protein gp51. J. Virol. Methods 23:211-222.
Reth, M. 1989. Antigen receptor tail clue. Nature (London) 338:383-384.
Rice, N., R. Stephens, and R. Gilden. 1987. Sequence analysis of the bovine leukemia virus genome, p. 115-144. In A. Burny and M. Mammerickx (ed.), Enzootic bovine leukosis and bovine leukemia virus. Nijhoff, The Hague, The Netherlands.
Sagata, N., T. Yasunaga, J. Tsuzuku-Kawamura, K. Ohishi, Y. Ogawa, and Y. Ikawa. 1985. Complete nucleotide sequence of the genome of bovine leukemia virus: its evolutionary relationship to other retroviruses. Proc. Natl. Acad. Sci. USA 82:677-681.
Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
Vonèche, V., D. Portetelle, R. Kettmann, L. Willems, K. Limbach, E. Paoletti, J. M. Ruyschaert, A. Burny, and R. Brasseur. 1992. Fusogenic peptides of bovine leukemia virus and simian immunodeficiency virus are interchangeable and mediate fusion by means of oblique insertion in the lipid bilayer of their target cells. Proc. Natl. Acad. Sci. USA 89:3810-3814.
Willems, L., C. Grimonpont, H. Heremans, N. Rebeyrotte, G. Chen, D. Portetelle, A. Burny, and R. Kettmann. 1992. Mutations in the bovine leukemia virus tax protein can abrogate the long terminal repeat-directed trans-activating activity without concomitant loss of transforming potential. Proc. Natl. Acad. Sci. USA 89:3957-3961.
Willems, L., H. Heremans, G. Chen, D. Portetelle, A. Billiau, A. Burny, and R. Kettmann. 1990. Cooperation between bovine leukemia virus transactivator protein and Ha-ras oncogene product in cellular transformation. EMBO J. 9:1577-1581.
Willems, L., P. Kerkhofs, F. Dequiedt, D. Portetelle, M. Mammerickx, A. Burny, and R. Kettmann. 1994. Attenuation of bovine leukemia virus by deletion of R3 and G4 open reading frames. Proc. Natl. Acad. Sci. USA 91:11532-11536.
Willems, L., R. Kettmann, F. Dequiedt, D. Portetelle, V. Vonèche, I. Cornil, P. Kerkhofs, A. Burny, and M. Mammerickx. 1993. In vivo infection of sheep by bovine leukemia virus mutants. J. Virol. 67:4078-4085.
Willems, L., D. Portetelle, P. Kerkhofs, G. Chen, A. Burny, M. Mammerickx, and R. Kettmann. 1992. In vivo transfection of bovine leukemia virus into sheep. Virology 189:775-777.
Zack, J., S. Arrigo, S. Weitsman, A. Go, A. Haislip, and I. Chen. 1990. HIV entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
